Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin-Reference-Cited by-同舟云学术

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

Published:2005-01 Issue:1 Volume:7 Page:73-82
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

De Leeuw I.,Vague P.,Selam J.-L.,Skeie S.,Lang H.,Draeger E.,Elte J. W. F.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2004.00363.x/fullpdf

Reference30 articles.

1. Reducing hypoglycaemia with insulin analogues

2. Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial

3. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

4. The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin: The Journey Continues;Journal of Marine Medical Society;2023-09-01

2. Comparison of Insulin Analogs and Human Insulins: A Narrative Review;Journal of Diabetes and Endocrine Practice;2023-08-10

3. The 2021–2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice;Diabetology & Metabolic Syndrome;2022-12-12

4. A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia;The Journal of Clinical Endocrinology & Metabolism;2022-12-07

5. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline;The Journal of Clinical Endocrinology & Metabolism;2022-12-07